Tag: carcinoid treatments

Ebrahim S. Delpassand, MD, FACNM

FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)

August 24, 2010

For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate. Ebrahim S. Delpassand, MD, chief executive officer and medical director of…

READ MORE
Michael J. Demeure, MD

Carcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment

March 23, 2010

Determining Molecular Signature:  A Guide for Targeted Therapy of Neuroendocrine Tumors

Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis.  This is the cutting-edge…

READ MORE
Laurie Todd Photo

New Message for Carcinoid Patients from “The Insurance Warrior”

February 28, 2010

 

Laurie Todd, “The Insurance Warrior,” has a special message for the carcinoid community.

The Carcinoid Cancer Foundation is delighted to partner with Laurie to bring you cutting-edge information about how to fight your insurance… READ MORE